Connect with me about:
Life After Mayo
First Job/Residency
Education
Research
I am a physician-scientist, pediatric cardiologist at Duke University School of Medicine. I care for children with heritable arrhythmias and sudden cardiac death-predisposing disease. I run a translational basic science laboratory exploring the genetic and molecular causes of sudden cardiac arrest.
Campus: Mayo Clinic in Rochester
Name: Mayo Clinic Alix School of Medicine
Degree: Medical Student
Specialty: M.D. - Ph.D.
Year: 2012
Campus: Mayo Clinic in Rochester
Name: Mayo Medical School (MMS)
Degree: Medical Student
Specialty: M.D. - Ph.D.
Year: 2012
Campus: Mayo Clinic in Rochester
Name: Mayo Medical School (MMS)
Degree: Medical Student
Specialty: Medicine
Year: 2005
Name: Baylor College of Medicine
Degree: Post-doctoral Research Fellowship
Specialty: Biophysics
Year: 2017
Name: Baylor College of Medicine/Texas Children\'s Hospital
Degree: Fellowship in Pediatric Cardiology
Specialty: Pediatric Cardiology
Year: 2017
Name: Baylor College of Medicine/Texas Children\'s Hospital
Degree: Residency in Pediatrics
Specialty: Pediatrics
Year: 2014
Name: Baylor College of Medicine/Texas Children\'s Hospital
Degree: Fellowship in Pediatric Electrophysiology
Specialty: Pediatric Cardiology
Year: 2018
Name: Mayo Clinic Alix School of Medicine
Degree: Medical Student
Specialty: –
Year: 2012
Name:
American Academy of Pediatrics
Role: –
Name:
American Heart Association
Role: –
Name:
Pediatric and Adult Congenital Electrophysiology Society
Role: –
Name:
American College of Cardiology
Role: –
Name:
Heart Rhythm Society
Role: –
The sudden death of an otherwise healthy child can devastate families and up-end entire communities. These deaths often represent the fringe of clinical medicine where answers to diagnosis, risk stratification, and individualized life-saving interventions demand knowledge of functional genomics and cellular physiology in addition to clinical medicine. As a physician-scientist trained in the confluence of pediatric cardiology, human genetics, and molecular pharmacology, I seek to leverage genomics, cellular physiology, and molecular biophysics to determine why these children die, how to identify at-risk family members, and how to target the specific molecular abrogation that perturbs these children’s hearts.